JB Chemicals launches medicated Nicotine lozenges: Quit smoking

The 'NOSMOK' medicated nicotine lozenges will be available in Mint flavour as sugar-based and sugar-free variants in 2mg and 4mg strengths.

165

Nicotine lozenges will help in reducing the urge to consume or smoke tobacco and relieve the psychological and psychomotor withdrawal symptoms and help them in their tobacco cessation journey.

The ‘NOSMOK’ medicated nicotine lozenges will be available in Mint flavour as sugar-based and sugar-free variants in 2mg and 4mg strengths. These lozenges are a part of the global JBCPL portfolio which are being introduced in India,” informed the company through a statement.

An AI-enabled Chatbot ‘Dr Will’ has also been launched to encourage and support tobacco smokers to quit smoking. The company informed that ‘Dr. Will’ is a digital program that will help smokers in understanding their smoking triggers and motivate them to succeed in quitting. It will also support doctors in counselling smokers to quit the habit.


Also read other article on Nicotine, click here


Prescription Medicine Doctor
Picture: Pixabay

Nikhil Chopra, CEO & Whole Time Director, JB Chemicals & Pharmaceuticals said, “Our study of the market led us to realise that a successful tobacco cessation initiative would require not just Nicotine replacement therapy but also patient education and support through the journey to quit smoking.

This has led to our launching nicotine replacement pharmacotherapy, NOSMOK accompanied by a digital AI-enabled WhatsApp based chatbot, ‘Dr Will’. We are confident that these will help tobacco users and smokers to successfully beat their habit and emerge tobacco free.”

JBCPL is one of the few companies to offer Nicotine replacement therapy in the form of medicated lozenges that contains nicotine. NOSMOK will be available on prescription at leading chemists across major centres in 2 mg lozenges and 4 mg lozenges form.

‘Dr Will’ is an AI-enabled chatbot to educate and counsel for tobacco cessation. The chatbot will answer patient queries related to quitting smoking options, make relevant information and support available to its users. It is designed as a support mechanism and a helping hand to aid in the journey of tobacco cessation.

PLI Scheme: Approvals accorded for Promotion of APIs

Zydus Cadila plans to test its C-19 vaccine for 5-12 age…

Black fungus treatment: IIT is ready for tech transfer of oral…

Take care of your Air, Don’t share it

Zydus Cadila gets USFDA nod for Fluphenazine HCL Tablets

NITI Aayog + Piramal to invest Rs 100 crores towards C-19…

Subscribe for daily free updates on Telegram

Follow us on Facebook and Linkedin

For daily free updates on WhatsApp, click here

Enter your email address:

Delivered by FeedBurner